Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study

OBJECTIVE: Dabigatran was recently approved for anticoagulation in patients with atrial fibrillation (AF); data regarding real-world use, comparative effectiveness and safety are sparse. DESIGN: Pharmacoepidemiological cohort study. METHODS/SETTINGS: From nationwide registers, we identified patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Sørensen, Rikke, Gislason, Gunnar, Torp-Pedersen, Christian, Olesen, Jonas Bjerring, Fosbøl, Emil L, Hvidtfeldt, Morten W, Karasoy, Deniz, Lamberts, Morten, Charlot, Mette, Køber, Lars, Weeke, Peter, Lip, Gregory Y H, Hansen, Morten Lock
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646187/
https://www.ncbi.nlm.nih.gov/pubmed/23645926
http://dx.doi.org/10.1136/bmjopen-2013-002758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646187/
https://www.ncbi.nlm.nih.gov/pubmed/23645926
http://dx.doi.org/10.1136/bmjopen-2013-002758

Ejemplares similares